Investigating the prognostic factors of IDH wild-type glioma based on the comprehensive genomic analysis
Project/Area Number |
17K10862
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Neurosurgery
|
Research Institution | Nagoya University |
Principal Investigator |
|
Project Period (FY) |
2017-04-01 – 2022-03-31
|
Project Status |
Completed (Fiscal Year 2021)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 低悪性度神経膠腫 / IDH1 / 悪性転化 / グリオーマ / IDH野生型神経膠腫 / 包括的ゲノムプロファイリング |
Outline of Final Research Achievements |
The clinical significance of genetic lesions within each lower-grade gliomas (LGG) subtype has not been fully elucidated. In this study, they identified sets of subtype-specific genetic and clinicopathological markers for each WHO subtype. The study subjects were a large cohort of patients who were genotyped for known or putative driver mutations and copy number variations associated with LGGs. Importantly, given that LGGs frequently have an indolent clinical history, the subjects were followed up for sufficiently long periods to accurately evaluate overall survival.
|
Academic Significance and Societal Importance of the Research Achievements |
低悪性度神経膠腫におけるDMBT1及びMET遺伝子の機能について、他に同様の報告はされていない。本研究において、DMBT1及びMET 遺伝子とgrade IIIグリオーマ細胞株の相互作用や悪性転化・増殖に関わる機能解析を行ったことで、腫瘍発生・進展・増殖及び悪性転化に関わるメカニズムの解明につながる。今後、難治性腫瘍である悪性グリオーマに対する新たな治療戦略の一つとして期待され、個別化医療の実現を可能にするバイオマーカーとなる可能性を秘めている。
|
Report
(6 results)
Research Products
(26 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Trautmann-focused mastoidectomy for a simple, safe presigmoid approach: technical note.2020
Author(s)
Tanahashi K, Uda K, Araki Y, Takeuchi K, Choo J, Chalise L, Motomura K, Ohka F, Wakabayashi T, Natsume A.
-
Journal Title
J Neurosurg.
Volume: 3
Issue: 3
Pages: 1-5
DOI
Related Report
Peer Reviewed
-
[Journal Article] H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant.2020
Author(s)
Maeda S, Ohka F, Okuno Y, Aoki K, Motomura K, Takeuchi K, Kusakari H, Yanagisawa N, Sato S, Yamaguchi J, Tanahashi K, Hirano M, Kato A, Shimizu H, Kitano Y, Yamazaki S, Yamashita S, Takeshima H, Shinjo K, Kondo Y, Wakabayashi T, Natsume A.
-
Journal Title
Acta Neuropathologica Communications
Volume: 8
Issue: 1
Pages: 8-19
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma.2019
Author(s)
Adilijiang A, Hirano M, Okuno Y, Aoki K, Ohka F, Maeda S, Tanahashi K, Motomura K, Shimizu H, Yamaguchi J, Wakabayashi T, Natsume A.
-
Journal Title
Molecules
Volume: 24(17)
Issue: 17
Pages: 3046-3046
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Neurocognitive and functional outcomes in patients with diffuse frontal lower-grade gliomas undergoing intraoperative awake brain mapping.2019
Author(s)
Motomura K, Chalise L, Ohka F, Aoki K, Tanahashi K, Hirano M, Nishikawa T, Yamaguchi J, Shimizu H, Wakabayashi T, Natsume A.
-
Journal Title
J Neurosurg.
Volume: 17
Issue: 6
Pages: 1-9
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study.2018
Author(s)
Wee CW, Kim IH, Park CK, Kim JW, Dho YS, Ohka F, Aoki K, Motomura K, Natsume A, Kim N, Suh CO, Chang JH, Kim SH, Cho WK, Lim DH, Nam DH, Choi JW, Kim IA, Kim CY, Oh YT, Cho O, Chung WK, Kim SH, Kim E.
-
Journal Title
Radiother Oncol.
Volume: 129(2)
Issue: 2
Pages: 347-351
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
[Journal Article] A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR.2018
Author(s)
Hirano M, Ohka F, Maeda S, Chalise L, Yamamichi A, Aoki K, Kato A, Tanahashi K, Motomura K, Nishimura Y, Hara M, Shinjo K, Kondo Y, Wakabayashi T, Natsume A.
-
Journal Title
Brain Tumor Pathol.
Volume: 35(2)
Pages: 97-105
Related Report
Peer Reviewed
-
-
[Journal Article] A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma.2017
Author(s)
Ohka F, Yamamichi A, Kurimoto M, Motomura K, Tanahashi K, Suzuki H, Aoki K, Deguchi S, Chalise L, Hirano M, Kato A, Nishimura Y, Hara M, Kato Y, Wakabayashi T, Natsume A.
-
Journal Title
Brain Tumor Pathol.
Volume: 印刷中
Issue: 2
Pages: 91-97
DOI
NAID
Related Report
Peer Reviewed